Wednesday, 7 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRA · BSE: 540788 · Healthcare · 31 announcements

Share price: ₹119.15
Market cap: ₹122.6 Cr
Revenue (annual): ₹24.98 Cr
Net profit (annual): ₹0.05 Cr
P/E (TTM): -271.0×Sector 53.1×
Promoter holding: 46.58%+28.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 7 Other Announcement 3 Open Offer 3 Management Change 3 Financial Results 3 Board Meeting Date 3 Promoter Buying (Off-Market) 2 Debt & Borrowing 2 Annual General Meeting 2 Promoter Reclassification 1 Fund Raise 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

12 Aug 2026 16:31 IST BSE

Financial Results

Aspira Pathlab & Diagnostics Q1 FY27 Results: Net Profit ₹0 Cr

Aspira Pathlab & Diagnostics Ltd reported revenue from operations of ₹6.2 Cr (+19.2% YoY) and net profit of ₹0 Cr for Q1 FY27.

Key figure: Net profit ₹0 Cr

Open full results → Read the filing ↗

23 May 2026 18:56 IST BSE

Financial Results

Aspira Pathlab & Diagnostics Q4 FY26 Results: Net Loss of ₹0.6 Cr

Aspira Pathlab & Diagnostics Ltd reported revenue from operations of ₹6.5 Cr (+12.1% YoY) and a net loss of ₹0.6 Cr for Q4 FY26.

Key figure: Net loss ₹0.6 Cr

Open full results → Read the filing ↗

23 May 2026 18:55 IST BSE

Financial Results

Aspira Pathlab & Diagnostics Financial Results

Aspira Pathlab approved its audited standalone financial results for the year ended March 31, 2026. The board also appointed new management and an internal auditor.

Read the filing ↗